Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropilin-1 (NRP1) is a non-tyrosine kinase transmembrane glycoprotein that functions as a co-receptor for various ligands, including vascular endothelial growth factor A (VEGFA) and class 3 semaphorins such as SEMA3A. It plays critical roles in angiogenesis, neuronal development, immune regulation, and cell migration/survival. NRP1 is widely expressed and upregulated in many cancers, making it an attractive therapeutic target.
Targeting NRP1 may enhance cancer immunotherapy efficacy without compromising peripheral tolerance. Facilitates SARS-CoV-2 entry into host cells; considered a potential antiviral drug target due to this function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropilin-1 Receptor (NRP1).